Literature DB >> 29986284

'A smile is most important.' Why chains are not currently the answer to quality concerns in the Indian retail pharmacy sector.

Rosalind Miller1, Eleanor Hutchinson2, Catherine Goodman3.   

Abstract

Chain pharmacies are expanding in many low and middle-income countries (LMICs). Historically practices of independent pharmacies in these settings have been poor, and there is a need to understand how these new organisational arrangements are affecting the functioning of pharmacies, and the implications for public health. Drawing on economics literature, we develop a set of hypotheses as to how chains could address the quality failures that typify LMIC retail pharmacy markets, and explore these hypotheses using a set of 38 in-depth interviews, conducted in Bengaluru, India between 2014 and 2015. We look specifically at how being organised in a chain affects several key behaviours: employment of qualified staff; the ability of government authorities to focus regulation on central management structures; the propensity for firms to self-regulate; and the impact of the potentially lower-powered incentives faced by chain employees compared to independent owners. In practice, few differences were identified between chain and independent organisations in these areas. Not all chains were operating with a qualified pharmacist (akin to independent shops). Drug control authorities did not take advantage of the existing chain architecture to enforce regulation. Chains did heavily self-regulate but their focus was on customer service, rather than aspects of quality relevant to health outcomes. Additionally, widespread bribery in the sector was a barrier to effective drug control. Finally, the incentives faced by chain employees were not low-powered due to rewarding sales targets and pressure to increase sales. We observed that chains exerted strong influence over their staff but the potential to exploit this to improve quality of care is not currently being realised. A shift in focus from customer satisfaction to outcomes of public health concern is unlikely without either financial incentives or strengthened external regulation.
Copyright © 2018 The Authors. Published by Elsevier Ltd.. All rights reserved.

Keywords:  Chain pharmacies; Health sector regulation; India; Pharmacies; Private sector; Quality of care

Mesh:

Year:  2018        PMID: 29986284     DOI: 10.1016/j.socscimed.2018.07.001

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  3 in total

1.  Governance to address health systems pitfalls of antibiotics overuse in low- and middle-income countries.

Authors:  Igor Francetic
Journal:  Int J Public Health       Date:  2019-08-29       Impact factor: 3.380

2.  Cheaper Medicines for the Better Off? A Comparison of Medicine Prices and Client Socioeconomic Status Between Chain and Independent Retail Pharmacies in Urban India.

Authors:  Rosalind Miller; Catherine Goodman
Journal:  Int J Health Policy Manag       Date:  2022-05-01

3.  What are the challenges for antibiotic stewardship at the community level? An analysis of the drivers of antibiotic provision by informal healthcare providers in rural India.

Authors:  Meenakshi Gautham; Neil Spicer; Soumyadip Chatterjee; Catherine Goodman
Journal:  Soc Sci Med       Date:  2021-03-06       Impact factor: 4.634

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.